• Profile
Close

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients

Pharmacogenomics and Personalized Medicine Aug 18, 2017

Salgado PC, et al. – The influence of the PPP3CA c.249G>A variant on the clinical outcomes of kidney transplant recipients, was examined. The clinical outcomes of Brazilian patients in the early phase of tacrolimus (TAC)–based immunosuppressive regimen were not impacted by the PPP3CA c.249G>A variant.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay